Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00621348Phase 3Completed
Phase 3, randomised, open-label trial of sodium chloride in hyponatremia, sponsored by AIIMS New Delhi. Primary endpoint: Incidence of Hyponatremia at 72 hours. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00621348.